Ocera Therapeutics (OCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,617 | -7,514 | -26,522 | -19,447 | -12,872 |
| Depreciation Amortization | 160 | 81 | 657 | 498 | 351 |
| Accounts receivable | N/A | -34 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 734 | 544 | -240 | 73 | 134 |
| Other Working Capital | 1,441 | 1,102 | 1,274 | 958 | 471 |
| Other Operating Activity | 1,431 | 596 | 4,217 | 2,787 | 1,768 |
| Operating Cash Flow | $-10,851 | $-5,225 | $-20,614 | $-15,131 | $-10,148 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,130 | -21 | 33,280 | 15,632 | 7,978 |
| PPE Investments | N/A | N/A | -75 | -89 | N/A |
| Investing Cash Flow | $6,130 | $-21 | $33,205 | $15,543 | $7,978 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | 9,748 | 9,748 | N/A |
| Common Stock Issued | 2,993 | 1,757 | 3,455 | 2,480 | 413 |
| Financing Cash Flow | $2,993 | $1,757 | $13,203 | $12,228 | $413 |
| Beginning Cash Position | 35,921 | 35,921 | 10,127 | 10,127 | 10,127 |
| End Cash Position | 34,193 | 32,432 | 35,921 | 22,767 | 8,370 |
| Net Cash Flow | $-1,728 | $-3,489 | $25,794 | $12,640 | $-1,757 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,851 | -5,225 | -20,614 | -15,131 | -10,148 |
| Capital Expenditure | N/A | N/A | -75 | -89 | N/A |
| Free Cash Flow | -10,851 | -5,225 | -20,689 | -15,220 | -10,148 |